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Abstract 
Medicinal plants are important reservoirs of bioactive compounds that need to be explored systematically. 
Because of their chemical diversity, natural products provide limitless possibilities for new drug discovery. 
This study aimed to investigate the biochemical properties of crude extracts from fifteen Nepalese medicinal 
plants. The total phenolic contents (TPC), total flavonoid contents (TFC), and antioxidant activity were 
evaluated through a colorimetric approach while the antibacterial activities were studied through the 
measurement of the zone of inhibition (ZoI) by agar well diffusion method along with minimum inhibitory 
concentrations (MIC) by broth dilution method. The methanolic extracts of Acacia catechu and Eupoterium 
adenophorum showed the highest TPC (55.21 ± 11.09 mg GAE/gm) and TFC (10.23 ± 1.07 mg QE/gm) among 
the studied plant extracts. Acacia catechu showed effective antioxidant properties with an IC50 value of 1.3 
μg/mL, followed by extracts of Myrica esculenta, Syzygium cumini, and Mangifera indica. Morus australis 
exhibited antibacterial activity against Klebsiella pneumoniae (ZoI: 25mm, MIC: 0.012 mg/mL), Staphylococcus 
aureus ATCC 25923 (ZoI: 22 mm, MIC: 0.012 mg/mL), Pseudomonas aeruginosa (ZoI; 20 mm, MIC: 0.05 mg/mL), 
and methicillin-resistant Staphylococcus aureus (MRSA) (ZoI: 19 mm, MIC: 0.19 mg/mL). Morus australis extract 
showed a broad-spectrum antibacterial activity, followed by Eclipta prostrata, and Hypericum cordifolium. Future 
study is recommended to explore secondary metabolites of those medicinal plants to uncover further clinical 
efficacy. 
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Introduction 
The separation and identification of physiologically 
active chemicals and molecules from medicinal plants 
has resulted in innovative treatments and 
pharmaceutical advances. Secondary metabolites 
extracted from medicinal plants have played a 
significant role in upholding human health against 
various infectious diseases since ancient times. Plant 
extracts or their active phytoconstituents have been used 
as folk medicine by 80 % of the world's population in 
conventional therapies [1]. It is believed that over 50% of 
all modern clinical drugs are of natural product origin 
[2].  
Multidrug resistance (MDR) is characterized as an 
acquired non-susceptibility to at least one antimicrobial 
agent from three or more categories [3]. Mobile genetic 
elements such as interferons, plasmids, and transposons 
are the most common carriers of antibiotic resistance 
among bacteria [4]. The rapid emergence of resistance to 
newly introduced antimicrobial agents, suggests that 
even a new antimicrobial agent would not be a complete 
solution to the problem [5]. MDR pathogens have raised 
a significant problem in public health by undermining 
the existing antibiotic-based treatment era, resulting in 
an increased mortality rate in patients [6]. MDR 
pathogens worsen the disease severity and put the value 
of antibiotics at risk, affecting the global economy [7]. It 
is anticipated that if the race of antimicrobial resistance  
(AMR) keep rising, it would take the lives of nearly ten 
million peoples annually by 2050 [8]. Thus, a new 
antibacterial agent is urgently needed to treat MDR-
induced infections caused by pathogens such as 
Enterobacteriaceae, Staphylococcus aureus, extended-
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spectrum β-lactamase (ESBL) producing bacteria, 
among others [9]. 








Eclipta prostrata NCDB203 Bhringaraj 
Whole 
plants 
Shorea robusta NCDB212 Saal Leaves 
Smallanthus sonchifolius NCDB214 Yacon Leaves 
Hypericum cordifolium NCDB201 Arelu Leaves 
Mangifera indica NCDB211 Mango Leaves 
Morus australis NCDB210 Kimbu Barks 
Psidium guajava NCDB206 Guava Leaves 
Chrysanthemum indicium NCDB205 Godawari Leaves 
Myrica esculenta NCDB208 Kafal Leaves 
Urtica ardens NCDB213 Sisnoo Buds 
Pterocarpus marsupium NCDB204 Bijayasal Barks 
Eupoterium adenophoium NCDB202 Banmara Leaves 
Zingiber officinale NCDB200 Aaduwa Leaves 
Acacia catechu NCDB209 Khair Barks 
Syzygium cumini NCDB207 Jamun Leaves 
 Acinetobacter baumannii, Pseudomonas aeruginosa,  
Medicinal plants produce secondary metabolites that 
can tackle MDR pathogens. Furthermore, medicinal 
plants have immunomodulatory and antioxidant 
activity, which result in antibacterial properties. They 
have a wide range of immunomodulatory effects 
stimulating both non-specific and specific immunity 
[10]. Antimicrobial and antioxidant activity is found in 
phytochemicals such as vitamins (A, C, E, and K), 
tannins, carotenoids, polyphenols, flavonoids, alkaloids, 
saponins, pigments, enzymes, terpenoids, and minerals 
[11]. Nonetheless, analgesic, antibacterial, deodorizing, 
febrifuge, fungicidal, antiseptic, astringent, 
galactagogue, diuretic, antidepressant, insecticidal, 
antipyretic, and sedative properties have been recorded 
for volatile oils from plants (Blanco et al., 2009; Bekoe et 
al., 2018; Iscan et al. 2002). 
However, microorganisms have continuously evolved 
with a wide range of metabolic mechanisms to 
overcome drug effects [6]. Plant-derived drugs are a 
superior choice over synthetic drugs because of fewer 
side effects and adverse effects (Bindu Jacob & 
Narendhirakannan R.T., 2019; Verma et al., 2018). Nepal 
is rich in biodiversity and geographical condition with 
diverse flora, and numerous species are believed to 
possess curative properties. However, most of these 
claims lack scientific validation. The plants selected for 
this study are being used routinely by the indigenous 
people as remedies against various human diseases 
since ancient times. Therefore, the selected plants may 
contain certain important bioactive compounds that 
could have some medicinal and antimicrobial properties 
and some therapeutic value based on phytochemical 
constituents and their secondary metabolites. Hence, the 
antibacterial activity of plant extracts reported here 
would be beneficial to identify some potent secondary 
metabolites as future drug candidates for the 
therapeutic measures of MDR-strains-induced infections 
in Nepal and beyond. 
Materials and Methods  
Bacterial isolates 
Eight MDR bacterial strains: Acinetobacter spp. (628), 
Citrobacter freundii (377), methicillin-resistant 
Staphylococcus aureus (MRSA) (338), Klebsiella 
pneumoniae (386), Pseudomonas aeruginosa (484), 
Escherichia coli (2A), Morganella morganii (4331), and 
Xanthomonas spp. (767) were collected from the 
National Public Health Laboratory (NPHL), 
Kathmandu, and transferred aseptically to the 
laboratory of the Department of Biotechnology, National 
College for further study. All isolates were obtained 
from clinical specimens. Besides, ATCC strains such as 
E. coli 25922, S. aureus 25923, Salmonella Typhimurium 
14028, and K. pneumoniae 700603 were also collected 
from the NPHL stored at -20°C for further studies. 
Collection of plant materials 
Different parts (leaves, bark, fruit, roots, and stem) were 
collected based on the ethnomedicinal and traditional 
medicinal practices from different geographical regions 
of Nepal as depicted in Table 1 (Collection period: 
January to June 2017). The plant samples were identified 
by National Herbarium and Plant Laboratories, 
Godawari, Lalitpur, Nepal, and herbarium collections 
were deposited in the Department of Botany, National 
College, Khusibu, Kathmandu. 
Preparation of plant extracts 
The plant parts (mentioned in Table 1) were dried in the 
shade at room temperature, pulverized into the 
powders with the help of a grinding mill, and then 
soaked in methanol for 24 hours. Then, they were 
filtered, and the process was repeated three times with 
fresh methanol. To obtain plant extracts, the filtrates 
were concentrated in a rotary evaporator at 50 °C. 
Determination of TPC and TFC  
Using Folin-Ciocalteu reagent and a 96-well plate-based 
colorimetric process, The TPC was calculated 
(Ainsworth & Gillespie, 2007; Bhandari et al., 2021). 
Initially, 20 µL of plant extract was mixed with 100 µL of 
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Folin-Ciocalteu's reagent (1:10 v/v) and 80 µL of sodium 
carbonate (7.5%, w/v) in each well-containing standard 
and sample before incubation. Then, the sample was 
incubated at room temperature, and absorbance was 
measured at 765 nm[15]. By comparing TPC to standard 
gallic acid, milligrams of gallic acid equivalents per 
gram of extract (mg GAE/gm) were determined. 
Likewise, for TFC, 20 µL of plant extract was mixed with 
60 µL of methanol, 5 µL of potassium acetate (1 M), 5 µL 
of 10% aluminum chloride, and 110 µL of distilled 
water, then incubated at room temperature for 30 
minutes, and the absorbance was measured at 415 
nm[17]. Likewise, TFC was expressed as milligrams of 
quercetin equivalents per gram of extract (mg QE/gm 
extract) by comparing to standard quercetin [17]. 
Determination of antioxidant activity 
The antioxidant property was determined by 
discoloration assay based on the scavenging of 2, 2- 
diphenyl-1-picrylhydrazyl (DPPH) free radical (0.1 mM 
) (Brand-Williams et al., 1995; Aryal et al., 2021) at 517 
nm using a multi-plate reader (Epoch 2, BioTek, 
Instruments, Inc., USA), maintaining 1 mg/mL of 
quercetin as a control. Crude extracts were allowed to 
react with DPPH free radicals for 30 minutes at room 
temperature. The scavenging of DPPH radical was 
calculated by using the following expression: (where 
optical density (OD) is the absorbance). 





Using sterile cotton swabs moistened with the bacterial 
suspension, an inoculum suspension containing 1.5 x108 
CFU/mL of bacteria was spread on firm Muller-Hinton 
Agar (MHA) plates (Balouiri et al., 2016; Marasini et al., 
2015; Valgas et al., 2007). Using a sterile cork borer, 
wells were punched in plates (6 mm diameter) and 
micropipettes were used to fill the wells with a 
functioning suspension (50µL) of plant extracts (50 
mg/mL), as well as neomycin (20 µg /mL), amikacin (30 
mcg), and nitrofurantoin (30 mcg) as positive controls 
and 50 % DMSO as negative controls [23]. The MHA 
plates were incubated for 24 hours at 37°C and finally, 
the ZoI was determined after overnight incubation. 
Determination of MIC 
The broth dilution method was followed to determine 
MIC values of plant extracts as recommended by the 
Clinical and Laboratory Standards Institute [24]. 
Extracts of E. adenophorum, M. australis, E. prostrata, A. 
catechu, Z. officinale, P. marsupium, S. robusta, M. indica, S. 
sonchifolius, M. esculenta, U. ardens, H. cordifolium, S. 
cumini, P. guajava, and C. indicium showed significant 
antibacterial activity with larger ZoI, so they were 
selected for the determination of MIC value. The plant 
extracts were two-fold diluted to get a series of 
concentrations ranging from 25 mg/mL to 0.012 mg/mL 
in freshly prepared sterile nutrient broth. Then 20 µL of 
bacterial culture adjusted to 0.5 McFarland Standard 
was inoculated in each dilution tube and incubated at 
37˚C for 24 hours. The set-up included bacterial growth 
controls containing test tubes with media inoculated 
with 20 µL of bacterial inoculum only and negative 
controls with media and plant extract without bacterial 
inoculum. The MIC value was measured by choosing 
the lowest concentration of plant extract that inhibited 
the organism's growth in the test tubes, as determined 
by unaided observation. The bacterial growth in the 
tubes containing the plant extracts was compared to the 
control sample without the plant extracts to establish the 
growth endpoints. Each assay was carried out in 
triplicate to confirm the results. 
Results 
The researches on medicinal plants have been carried 
throughout the world to explore the bioactive 
compounds which could be used to make a preventive 
or treatment approach against various health 
complications. The ethnopharmacological applications 
of plants under study were depicted in Table 2. 
Yields, TPC and TFC of plant extracts 
The percentage yield of plant extracts varied from 5.94% 
to 28.47% (Table 3). Extracts of H. cordifolium had the 
highest percentage yield (28.47%), followed by A. 
catechu (23.0%), P. guajava (21.82%), and M. esculenta 
(19.02%). Noticeably all plant extracts were found to be 
in semi-solid inconsistency.  
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Table 2: Medicinal plants selected understudy with their ethnopharmacological applications 
Medicinal plants Family Ethnopharmacological applications 
Eclipta prostrata Asteraceae 
Used as an anti-inflammatory, antivenom [25], anti-aging, hepatoprotective, anti-viral, 
antimicrobial agents. Bithiophenes and 5-(but-3-yne-1,2-diol)-5′-hydroxy-methyl-
2,2′bithiophene isolated from this plant used as antibacterial and antihyperglycemic 
[26], [27]. 
Shorea robusta Dipterocarpaceae 
Used in the treatment of ulcer, cough, itching, leprosy, anthelmintic [28].  Antibacterial 
wound healing and anti-inflammatory activity due to the presence of polyphenols, 
flavonoids, and triterpenoids, etc. Ursolic acid extracted from this plant is responsible 
for showing antibacterial activity [29]. 
Smallanthus sonchifolius Asteraceae 
Used as a functional food, antioxidant, antimicrobial, prebiotic, growth promoter [30]. 
Leaves extract contains the compounds fluctuanin and enhydrin show antibacterial 
activity [31]. 
Hypericum cordifolium Hypericaceae 
Treatment of back pain and broken bones, an antidepressant [32]. Dermatological, 
neurological, and traumatological problems, antibacterial activity [33]. 
Mangifera indica Anacardiaceae 
Used for gastric disorders, mouth sores, tooth pain, and dermatological disorders. [34] 
Treatment for diabetes, infertility, ethanolic extract of M. indica showed significant 
antibacterial activity. Methanolic extract displayed cytotoxicity against the pancreatic 
cancer cell line. Magniferin (5) from plant extract showed antimicrobial effect [35], [36]. 
Morus australis Moraceae 
Treatment for fever, protect the liver, improve eyesight, strengthen joints, lower blood 
pressure [37]. Leaves contain 1-deoxynojirimycin known to have potential α- 
glucosidase inhibition activity. The piperidine alkaloid and glycoproteins from the 
extract of M. austrralis have been used for antidiabetic agents [38]. 
Psidium guajava Myrtaceae 
Used for ulcers, wounds, toothache, anti-allergic effects, anti-cancer effects, and anti-
hyperglycemia [39]. Used effectively in diabetes, diarrhea, dysentery, pain relief, cough, 
gastroenteritis, hypertension, caries. The hypoglycemic components in Psidium guajava 
might be due to oleanolic acid, arjunolic acid, ursolic acid, and glucuronic acid [40]. 
Chrysanthemum indicium Asteraceae 
Used for hypertension, pneumonia, colitis, stomatitis, fever, neurological problems, 
headache [41], antipyretic purpose, treatment of cephalgia, vertigo, and eye 
inflammations [42]. 
Myrica esculenta Myricaceae 
Used for cough, anemia, asthma, chronic dysentery, fever, sores, tumors, nasal catarrh, 
piles, throat complaints, ulcers, and urinary discharges[43]. Used against different 
disease conditions such as; antidiabetic, antiallergic, antimicrobial, anti-ulcer, anti-
hypertensive, antioxidant, and higher phenolic and flavonoid compounds including 
myricetin, myricanol, and myricanone have anti-inflammatory properties. [44]. 
Urtica ardens Urticaceae 
Used for diabetes, diarrhea, excessive menstrual bleeding, urinary disorders, respiratory 
problems, ulcers, asthma, rheumatism, high blood pressure [45]. Treatment for sprains, 
kidney stones, hemorrhoids, flu, fever, hepatoprotective, nephroprotective effect, etc. 
[46]. 
Pterocarpus marsupium Fabaceae 
Stomachache, cholera, dysentery, urinary complaints, tongue disease, toothache, and 
cough are all treated. [47]. Treatment of diabetes, jaundice, and an ulcer [48]. 
Eupoterium adenophoium Asteraceae 
Used for treatment of emetic, diaphoretic, stimulant, tonic, fever, cuts and wounds, 
analgesic [49]. Used as an anti-inflammatory, blood coagulant, antimicrobial, antiseptic, 
and analgesic, antipyretic. Isomers of mono-caffeoylquinic acid present in E. 
adenophoium exhibit potent anti-inflammatory, anti-bacterium, and anti-obesity 
properties [50]. 
Zingiber officinale Zingiberaceae 
Treatment of diabetes, high blood pressure, cancer, stomachache, nausea, asthma, 
respiratory disorders [51]. Treatment for diabetes, blood pressure, stomach ache, weight 
loss, diarrhea, and nausea. Geraniol present in Z. officinale shows potential anti-
inflammatory and antioxidant effects [52]. 
Acacia catechu Fabaceae 
It can be used to treat colds, coughs, ulcers, boils, and skin eruptions, bleeding masses, 
antipyretics, and acute and chronic wound healing. [53]. The key constituents of A. 
catechu are catechin and taxifolin, which have antifungal, antiviral, antibacterial, anti-
inflammatory, and antioxidant properties. [53]. 
Syzygium cumini Myrtaceae 
Used for diabetes mellitus, constipation, stomachache, HIV, inflammation leucorrhoea, 
fever, strangury, and dermopathy [54], [55]. Ferulic acid and Catechins possess 
antioxidant properties [56]. Gallocatechins are used to treat diabetes. Quercetin isolated 
from S. cumini is used to treat diabetes and treat cytotoxicity. 
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Table 3: Physical characteristics and percentage yield of the crude extracts. 
Medicinal plants Local Name Dry weight of plant (gm) Percentage yield (%) 
Hypericum cordifolium Arelu 40 28.46 
Acacia catechu Khayr 50 23.0 
Psidium guajava Guava 50 21.82 
Myrica esculenta Kafal 50 19.02 
Syzygium cumini Jamun 50 17.0 
Mangifera indica Mango 50 14.9 
Chrysanthemum indicium Godawari 50 13.44 
Zingiber officinale Ginger 50 12.5 
Smallanthus sonchifolius Ground apple 50 11.16 
Pterocarpus marsupium Bijayasal 50 11.02 
Eupoterium adenophorum Banmara 50 10.42 
Shorea robusta Sal 50 9.1 
Eclipta prostrata Bhringraj 70 6.54 
Morus australis Kimbu 34.8 6.03 
Urtica ardens Sisnoo 50 5.94 
Table 4: TPC of medicinal plants. 
Medicinal plants TPC (mg GAE/gm) 
Acacia catechu 55.21 ± 11.09 
Urtica ardens 50.01 ± 5.0 
Mangifera indica 49.88 ± 19.2 
Psidium guajava 45.21 ± 2.73 
Shorea robusta 45.21 ± 4.15 
Eupoterium adenophorum 37.61 ± 4.14 
Hypericum cordifolium 36.28 ± 2.37 
Chrysanthemum indicium 32.95 ± 4.43 
Syzygium cumini 28.28 ± 1.85 
Myrica esculenta 23.21 ± 4.42 
Pterocarpus marsupium 22.68 ± 1.35 
Morus australis 19.75 ± 2.94 
Zingiber officinale 19.21 ± 2.0 
Eclipta prostrata 18.95 ± 1.24 
Smallanthus sonchifolius 9.08 ± 1.01 
Table 5: TFC of medicinal plants. 
Medicinal plants TFC (mg QE/gm) 
Eupoterium adenophorum 10.23 ± 1.07 
Morus australis 9.10 ± 0.98 
Eclipta prostrata 8.67 ± 0.57 
Acacia catechu 8.34 ± 0.77 
Zingiber officinale 7.78 ± 0.71 
Pterocarpus marsupium 7.70 ± 0.85 
Shorea robusta 7.68 ± 0.71 
Mangifera indica 7.52 ± 1.12 
Smallanthus sonchifolius 7.40 ± 0.83 
Myrica esculenta 6.84 ± 1.30 
Urtica ardens 5.89 ± 0.35 
Hypericum cordifolium 5.89 ± 1.68 
Syzygium cumini 5.72 ± 0.52 
Psidium guajava 5.26 ± 1.15 
Chrysanthemum indicium 4.93 ± 0.66 
TPC of plant extracts was expressed in terms of gallic 
acid equivalent (mg GAE/gm dry weight of extract) and 
placed in the order from higher to lower using a 
calibration curve of gallic acid (y =0.0025x + 0.0413, R² = 
0.981). TPC of plant extracts ranged from 55.21 ± 11.09 to 
9.08 ± 1.0 mg GAE/gm. Extract of A. catechu exhibited 
the highest TPC, followed by U. ardens, M. indica, P. 
guajava, and S. robusta respectively (Table 4). 
Similarly, TFC of plant extracts was expressed in terms 
of quercetin equivalent (mg QE/gm) and placed in the 
order from higher to lower using a calibration curve of 
quercetin (y = 0.0202x – 0.972, R² = 0.972). The extract of 
E. adenophorum showed the highest TFC (10.23 ± 1.07 mg 
QE/gm), followed by M. australis and E. prostrata 
respectively (Table 5).  
Antioxidant activity 
Free radical scavenging activity was used to assess the 
antioxidant activity of plant extracts, and the resulting 
degree of decolorization is stoichiometric in terms of the 
number of electrons captured from plant extracts.  
The results of antioxidant abilities of plant extracts were 
compared with standard quercetin (IC50 2.28 µg/mL). 
Among them, methanolic extract of A. catechu, M. 
esculenta, S.  cumini, and M. indica showed promising 
antioxidant properties with IC50 ranging 1.3-1.80 µg/mL 
(Table 6). 
Evaluation of antibacterial activity 
Plant extracts were examined for antibacterial activity 
against eight MDR bacteria and four ATCC bacterial 
species adopting the agar well diffusion technique. The 
extracts of M. australis, S. robusta, and M. indica showed 
the largest ZoI i.e. 21 mm at 50 mg/mL towards E. coli 
ATCC 25922 in agar plates. Meanwhile, only E. prostrata 
extract showed 7 mm of the ZoI against K. pneumoniae 
ATCC 700603. The M. australis extract showed 22 mm of 
the ZoI against S. aureus ATCC 25923, which was the 
highest among the ZoI shown by plant extract. 
Similarly, M. australis extract showed the highest ZoI 
against three MDR bacterial strains, K. pneumoniae, 
MRSA, and P. aeruginosa with 25 mm, 19 mm, and 20 
mm, respectively (Table 8).   
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Table 6: IC50 values of plant extracts for antioxidant assay. 
Medicinal plants IC50 (µg/mL) 
Smallanthus sonchifolius 329.0 ± 0.01 
Morus australis 208.60 ± 0.02 
Pterocarpus marsupium 38.50 ± 0.04 
Shorea robusta 2.50 ± 0.01 
Mangifera indica 1.80 ± 0.06 
Syzygium cumini 1.60 ± 0.04 
Myrica esculenta 1.50 ± 0.03 
Acacia catechu 1.30 ± 0.05 
Quercetin (Standard) 2.28  
Note: only significant results were shown and placed in order from higher 
to lower IC50 value. 
The extract of S. robusta and M. indica showed 17 mm of 
the ZoI against MDR A. baumannii. Figure 1, presents 
ZoI of plant extracts against ATCC strains E. coli and S. 
aureus while Figure 2, presents ZoI of plant extracts 
against the MDR K. pneumoniae and Xanthomonas 
species. 
Figure 1. Antibacterial activity of plant extracts against ATCC 
organism E. coli and S. aureus: A) Neomycin; B) 50% DMSO; 
C) E. prostrata; D) P. marsupium; E) A. catechu: F) M. indica; 
G) S. robusta; H) C. indicium. 
Although some plant extracts exhibited potent 
antimicrobial activity towards some bacterial species, a 
higher number of plant extracts had a minimum 
antibacterial effect. The MIC of plant extracts against 
ATCC strains was between 0.012 mg/mL to 25 mg/mL 
(Table 9). Extracts of M. australis and H. cordifolium 
showed a broad-spectrum antimicrobial activity against 
Gram-positive and Gram-negative bacteria such as K. 
pneumoniae, E. coli, and S. aureus. The most potent 
antibacterial activity (MIC = 0.012 mg/mL) was shown 
by extracts of M. australis, H. cordifolium, and P. guajava, 
and the least antibacterial activity (MIC = 25 mg/mL) 
was observed in extracts of E. prostrata and S. cumini 
against ATCC strain of S.aureus. Regarding MDR 
strains, the most potent antibacterial activity (MIC = 
0.012 mg/mL) was shown by the extracts of M. australis 
and H. cordifolium against K. pneumoniae (386), followed 
by M. australis against Xanthomonas species (4331) and P. 
aeruginosa (484) (Table 10). 
Figure 2. Antibacterial activity of plant extracts against MDR 
K.pneumoniae and Xanthomonas species; A) Neomycin; B) 50% 
DMSO; C) H. cordifolium; D) S. cumini; E) M. australis: F) A. 
catechu; G) M. indica; H) P. marsupium; I) M. esculenta. 
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Eupoterium adenophorum 12 - - 11 
Morus australis 21 - - 22 
Eclipta prostrata 9.0 7.0 - 11 
Acacia catechu 18 - - 15 
Zingiber officinale - - - - 
Pterocarpus marsupium 12 - - 14 
Shorea robusta 21 - - 17 
Mangifera indica 21 - - 14 
Smallanthus sonchifolius - - - - 
Myrica esculenta 16 - - 19 
Urtica ardens - - - - 
Hypericum cordifolium 10 - - 18 
Syzygium cumini 17 - - 13 
Psidium guajava 16 - - 15 
Chrysanthemum indicium 8.0 - - 12 
Neomycin 22 10 15 20 
50% DMSO - - - - 
Diameter of zone of inhibition in mm, well diameter = 6 mm, (-) = No antibacterial activity 
 
Discussion 
In developing health care, the search for new medicines 
with better or enhanced therapeutic actions derived 
from medicinal plants with ethnobotanical significance 
has become increasingly valuable [57,58]. Extraction is 
the most important step in obtaining the plant's 
bioactive compounds, and the yield is determined by 
the solvent and extraction method used [59]. In this 
study, methanol was used as a solvent with a  
Table 8: Antibacterial activity of plant extracts against MDR bacterial strains. 
Medicinal plants 
Bacterial strains 
2A 386 338 628 377 767 4331 484 
Eupoterium adenophorum - - - 13 - 15 11 - 
Morus australis - 25 19 14 - 15 - 20 
Eclipta prostrata - 10 - 16 - 10 9.0 - 
Acacia catechu - 14 - 12 - 14 - - 
Zingiber officinale - - - - - - - - 
Pterocarpus marsupium - - 13 12 - 17 11 - 
Shorea robusta - - - 17 - - - - 
Mangifera indica - - - 17 - 12 - - 
Smallanthus sonchifolius - - - 9.0 - - - - 
Myrica esculenta - - - 13 - 15 16 - 
Urtica ardens - - - - - - 9 - 
Hypericum cordifolium - 20 12 16 - - - 20 
Syzygium cumini - 16 16 14 - 17 - - 
Psidium guajava - - 12 14 - 17 - - 
Chrysanthemum indicium - - 15 15 - 8.0 - - 
Neomycin 15 23 15 - - 11 - 10 
50% DMSO - - - - - - - - 
Amikacin - - 23 20 - - 15 23 
Nitrofurantoin 22 18 16 - 17 16 - 15 
(-) No antibacterial activity, 2A = E. coli, 338 = methicillin-resistant S. aureus (MRSA), 386 = K. pnemoniae, 628 = A. baumannii, 377 = 
C. freundii, 767 = Xanthomonas species, 4331 = M. morganii, 484 = P. aeruginosa 
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percentage yield of H. cordifolium being the highest 
(28.46 %) followed by A. catechu (23 %) (Table 3). The 
methanolic extract of A. catechu showed the highest TPC, 
while the extract of E. adenophorum showed the highest 











Eupoterium adenophorum - - - - 
Morus australis  3.125 6.25 - 0.012 
Eclipta prostrata 6.25 - - 25.0 
Acacia catechu 0.39 - - 6.25 
Zingiber officinale - - - - 
Pterocarpus marsupium 12.5 - - 1.56 
Shorea robusta 3.125 - - 12.5 
Mangifera indica 0.39 - - 12.5 
Smallanthus sonchifolius - - - - 
Myrica esculenta 0.097 - - 1.56 
Urtica ardens - - - - 
Hypericum cordifolium 6.25 6.25 - 0.012 
Syzygium cumini 0.39 - - 25.0 
Psidium guajava 0.39 - - 0.012 
Chrysanthemum indicium 6.25 - - - 
Neomycin 0.39 3.12 0.78 0.39 
50% DMSO - - - - 
Diameter of zone of inhibition in mm, well diameter = 6 mm, (-) = No antibacterial activity reported. Neomycin serves as positive control 
while 50% DMSO serves as a negative control for the test. The concentration of plant extracts expressed in mg/ml. 
Table 10: MIC of plant extracts against MDR bacterial strains. 
Medicinal plants 
Bacterial strains 
386 338 628 767 4331 484 
Eupoterium adenophorum 1.56 - - - - - 
Morus australis 0.012 0.19 3.12 0.05 - 0.05 
Eclipta prostrata 1.56 - 6.25 3.12 12.5 - 
Acacia catechu 0.78 - 6.25 1.56 - - 
Zingiber officinale - - - - - - 
Pterocarpus marsupium 0.39 1.56 3.12 0.39 12.5 - 
Shorea robusta - - 6.25 - - - 
Mangifera indica - - 3.12 0.78 - - 
Smallanthus sonchifolius - - 6.25 - - - 
Myrica esculenta 0.39 12.5 3.12 1.56 6.25 - 
Urtica ardens - - - - 12.5 - 
Hypericum cordifolium 0.012 0.19 6.25 - - 0.78 
Syzygium cumini 0.19 - 6.25 0.78 - - 
Psidium guajava - 3.12 3.12 1.56 - - 
Chrysanthemum indicium - 1.56 6.25 1.56 - - 
50% DMSO - - - - - - 
Neomycin 0.78 6.25 - - 12.5 0.012 
Amikacin - 3.12 3.12 - 6.25 0.78 
Nitrofurantoin 3.12 - - 3.12 - 0.78 
(-) No antibacterial activity, 2A = E. coli, 338 = methicillin-resistant S. aureus (MRSA), 386 = K. pneumoniae, 628 = A. 
baumannii, 377 = C. freundii, 767 = Xanthomonas species, 4331 = M. morganii, 484 = P. aeruginosa. Neomycin, Amikacin and 
Nitrofurantoin were used as positive control and 50% DMSO as negative control for test. The concentration of plant 
extracts expressed in mg/ml. 
Nepal J Biotechnol. 2021  Jul ;9 (1): 5 0 -62      Shrestha et al. 
 
©NJB, BSN  58 
TFC values of 55.21 ± 11.09 mg GAE/gm and 10.23 ± 
1.07 mg QE/gm respectively (Table 4 and Table 5). A. 
catechu had the highest free radical scavenging activity 
in the DPPH assay, followed by M. esculenta, S. cumini, 
and S. robusta. Flavonoid and phenolic compounds from 
plants have been shown to have free radical scavenging 
activity and antioxidant properties, according to 
previous research [60]. The methanolic extract of A. 
catechu shows the IC50 of about 84.9 ± 1.9 µg/mL while 
1.30 ± 0.05  µg/mL in our study [19]. The difference 
might be due to environmental variation, temperature, 
harvesting time, and temperature.  These antioxidant 
mechanisms defend humans from infections and 
degenerative diseases by inhibiting and scavenging free 
radicals [61]. 
The present study showed selected plant extracts 
possessed antibacterial activity; E. prostrata showed 
potential antibacterial activity against the ATCC strain 
of E. coli, S. aureus, and K. pneumoniae with ZoI ranging 
from 7 mm to 11 mm. Meanwhile, against MDR strains, 
the extract of E. prostrata showed ZoI against 
Acinetobacter spp. (628), K. pneumoniae (386), Morganella 
morganii (4331), and Xanthomonas spp. (767). Previous 
studies also support the antibacterial and antifungal 
activity of E. prostata (Chung et al., 2017; Khanna & 
Kannabiran, 2008). Cherdtrakulki at et al. (2015) 
reported that bioactive compounds isolated from the 
aerial parts of E. prostrata such as triterpenoids, 3-
acetylaleuritolic acid, stigmasterol, a mixture of 
triterpenoids, fatty esters, and aromatic components, 
had effective antimicrobial activity 
against Corynebacterium diphtheria NCTC 10356, 
Morexella catarrhalis, Streptococcus pyogenes and 
Saccharomyces cerevisiae ATCC 2601. Another study 
suggests the presence of alkaloids, cardiglycosides, 
phytosterol, beta-amyrin, polyacetylene, caffeic acid, 
stigmasterol, daucosterol on E. prostrata extracts and are 
found to be effective against K. pneumoniae, S. 
dysenteriae, E. coli, S. Typhi, B. subtilis, P. aeruginosa, and 
S. aureus [26]. Recently, ecliprostins A, B, and C isolated 
from this plant showed MIC of  25.0, 6.25 and 25.0 M, 
respectively towards the growth of S. aureus [64]. 
M. australis extract showed a wide range of antibacterial 
activity against the MDR strains of Acinetobacter spp. 
(628), methicillin-resistant S. aureus (MRSA) (338), K. 
pneumoniae (386), P. aeruginosa (484), and Xanthomonas 
spp. (767) with MIC value of 3.12 mg/mL, 0.19 mg/mL, 
0.012 mg/mL, 0.05 mg/mL and 0.05 mg/mL 
respectively. A similar kind of result was observed by 
Wei et al. (2016) against a wide range of pathogens such 
as S. aureus, Fusarium roseum, S. faecalis,  B. cereus,  E. 
coli,  K. pneumoniae, P. aeruginosa, Salmonella enterica 
serovar typhi,  C. freundii, Candida albicans, Microsporum 
audouinii, B. subtilis, Micrococus flavus,  and Salmonella 
abony due to presence of phytoconstituents such as that 
mulberrofuran, moracins, oxyresveratrol, morusin, and 
kuwanon C isolated from methanolic extract of Morus 
plant’s root bark. Other plant extracts such as P. 
marsupium, M. esculenta, H. cordifolium also exhibited 
antibacterial activity against MDR strains with varying 
MIC values (Table 9 and Table 10).  
The plant extracts might have a wide variety of 
phytochemicals that have different mechanisms of 
action for their antimicrobial activity [66]. By inhibiting 
enzymes and highly oxidizing compounds, phenol or 
hydroxylated phenol inhibits bacterial development, 
likely through reaction with sulfhydryl groups or 
nonspecific interactions with proteins [67]. 
Antimicrobial effects are possibly due to flavonoid’s 
ability to bind to extracellular and soluble proteins, as 
well as bacterial cell walls, inactivate enzymes, and 
disrupt microbial membranes [68]. Tannins function as 
antimicrobials by binding to adhesins, inhibiting 
enzymes, depriving bacteria of their food, forming a 
complex with the cell wall, disrupting membranes, and 
complexing metal ions [69]. Terpenoids and essential 
oils show antimicrobial activity by membrane 
disruption by the lipophilic compounds.  Alkaloid acts 
as an antimicrobial agent by intercalating into the cell 
wall and DNA of parasites [10]. These results indicate 
that Nepalese medicinal plants contain different 
phytochemicals that need to be explored further to 
acquire a future drug candidate against MDR 
pathogens. 
Conclusion 
Medicinal plants have long been used as traditional 
healers for a range of infections, and they are also useful 
in the formulation of drugs to treat a variety of 
conditions. The leaves extract of E. andenophorum 
showed the highest TFC (10.23 ± 1.07 mg QE/gm) while 
bark extract of A. catechu showed a high TPC (55.21 ± 
11.09 mg GAE/gm). Morus australis showed a broad-
spectrum antibacterial activity that might be a potential 
source of the future drug to treat MDR-associated 
infections. Similarly, other plant extracts such as E. 
prostrata, M. esculenta, P. marsupium, and H. cordifolium 
also showed potential antibacterial activity against 
clinical isolates of MDR bacteria. Future studies are 
anticipated to examine the possibility of these plants in 
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ethnomedicine and drug discovery to treat infections 
caused by drug-resistant pathogens. 
Availability of data and materials 
Plant specimen herbaria are kept in the National 
College, Kathmandu, and can be retrieved as needed. 
Data supporting this manuscript are accessible upon 
appropriate request to the corresponding author. 
Conflict of interests 
We announce that none of the writers have a conflict of 
interest in reporting these results. 
Funding statement 
Not applicable 
List of abbreviations 
American type culture collection (ATCC); Minimum 
inhibitory concentrations (MIC); Multidrug-resistant 
(MDR); Optical density (OD); The inhibitory 
concentration of drug/extract that gives half-maximal 
response (IC50); Total phenol contents (TPC); Total 
flavonoid contents (TFC); Zone of inhibition (ZoI); 2,2-
diphenyl-1-picrylhydrazyl (DPPH) 
References 
1. WHO. (2019). WHO global report on traditional and 
complementary medicine 2019. World Health 
Organization. 
https://apps.who.int/iris/handle/10665/312342 
2. Kirbağ SE, Zengin F, Kursat M. (2009). 
Antimicrobial activities of extracts of some plants. 
Pakistan J. of Botany, 41(4), 2067-70.  
3. Magiorakos, A.-P., Srinivasan, A., Carey, R. B., 
Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, 
S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, 
B., Paterson, D. L., Rice, L. B., Stelling, J., 
Struelens, M. J., Vatopoulos, A., Weber, J. T., & 
Monnet, D. L. (2012). Multidrug-resistant, 
extensively drug-resistant and pandrug-resistant 
bacteria: An international expert proposal for interim 
standard definitions for acquired resistance. Clinical 
Microbiology and Infection, 18(3), 268–281. 
https://doi.org/10/bbqpzj 
4. Tavares, L. S., Silva, C. dos S. F. da, Souza, V. C., 
Silva, V. L. da, Diniz, C. G., & Santos, M. D. O. 
(2013). Strategies and molecular tools to fight 
antimicrobial resistance: Resistome, transcriptome, 
and antimicrobial peptides. Frontiers in 
Microbiology, 4, 412. https://doi.org/10/ghf5qc 
5. Sommer, M. O., & Dantas, G. (2011). Antibiotics 
and the resistant microbiome. Current Opinion in 
Microbiology, 14(5), 556–563. 
https://doi.org/10/b6ttxr 
6. Lima, R., Del Fiol, F. S., & Balcão, V. M. (2019). 
Prospects for the Use of New Technologies to 
Combat Multidrug-Resistant Bacteria. Frontiers in 
Pharmacology, 10. 
https://doi.org/10.3389/fphar.2019.00692 
7. Aslam, B., Wang, W., Arshad, M. I., Khurshid, M., 
Muzammil, S., Rasool, M. H., Nisar, M. A., Alvi, R. 
F., Aslam, M. A., Qamar, M. U., Salamat, M. K. F., 
& Baloch, Z. (2018). Antibiotic resistance: A 
rundown of a global crisis. Infection and Drug 
Resistance, 11, 1645–1658. 
https://doi.org/10.2147/IDR.S173867 
8. Tagliabue, A., & Rappuoli, R. (2018). Changing 
Priorities in Vaccinology: Antibiotic Resistance 
Moving to the Top. Frontiers in Immunology, 9, 
1068. https://doi.org/10.3389/fimmu.2018.01068 
9. Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, 
M. S., & Pardesi, K. R. (2019). Emerging Strategies 
to Combat ESKAPE Pathogens in the Era of 
Antimicrobial Resistance: A Review. Frontiers in 
Microbiology, 10, 539. https://doi.org/10/ghfddk 
10. Othman, L., Sleiman, A., & Abdel-Massih, R. M. 
(2019). Antimicrobial Activity of Polyphenols and 
Alkaloids in Middle Eastern Plants. Frontiers in 
Microbiology, 10, 911. 
https://doi.org/10.3389/fmicb.2019.00911 
11. Nascimento, G. G. F., Locatelli, J., Freitas, P. C., & 
Silva, G. L. (2000). Antibacterial activity of plant 
extracts and phytochemicals on antibiotic-resistant 
bacteria. Brazilian Journal of Microbiology, 31(4), 
247–256. https://doi.org/10.1590/S1517-
83822000000400003 
12. Blanco, M. M., Costa, C. A. R. A., Freire, A. O., 
Santos, J. G., & Costa, M. (2009). Neurobehavioral 
effect of essential oil of Cymbopogon citratus in 
mice. Phytomedicine, 16(2), 265–270. 
https://doi.org/10.1016/j.phymed.2007.04.007 
13. Bekoe, E. O., Kitcher, C., Gyima, N. A. M., 
Schwinger, G., & Frempong, M. (2018). Medicinal 
Plants Used as Galactagogues. Pharmacognosy - 
Medicinal Plants. https://doi.org/10/ghf3rm 
14. Işcan, G., Ki̇ri̇mer, N., Kürkcüoǧlu, M., Hüsnü Can 
Başer, & Demi̇rci̇, F. (2002). Antimicrobial 
Screening of Mentha piperita Essential Oils. Journal 
of Agricultural and Food Chemistry, 50(14), 3943–
3946. https://doi.org/10/cs7jf8 
15. Ainsworth, E. A., & Gillespie, K. M. (2007). 
Estimation of total phenolic content and other 
oxidation substrates in plant tissues using Folin–
Ciocalteu reagent. Nature Protocols, 2(4), 875–877. 
https://doi.org/10.1038/nprot.2007.102 
16. Bhandari, S., Khadayat, K., Poudel, S., Shrestha, S., 
Shrestha, R., Devkota, P., Khanal, S., & Marasini, B. 
P. (2021). Phytochemical analysis of medicinal 
plants of Nepal and their antibacterial and antibiofilm 
activities against uropathogenic Escherichia coli. 
BMC Complementary Medicine and Therapies, 
21(1), 116. https://doi.org/10/gk45f5 
17. Joubert, E., Manley, M., & Botha, M. (2008). 
Evaluation of spectrophotometric methods for 
screening of green rooibos (Aspalathus linearis) and 
green honeybush (Cyclopia genistoides) extracts for 
high levels of Bio-active compounds. Phytochemical 
Analysis, 19(2), 169–178. https://doi.org/10/dv3t8n 
18. Brand-Williams, W., Cuvelier, M. E., & Berset, C. 
(1995). Use of a free radical method to evaluate 
Nepal J Biotechnol. 2021  Jul ;9 (1): 5 0 -62      Shrestha et al. 
 
©NJB, BSN  60 
antioxidant activity. LWT - Food Science and 
Technology, 28(1), 25–30. 
https://doi.org/10.1016/S0023-6438(95)80008-5 
19. Aryal, B., Niraula, P., Khadayat, K., Adhikari, B., 
Chhetri, D., Sapkota, B., Bhattarai, B., & Parajuli, N. 
(2021). Antidiabetic, Antimicrobial, and Molecular 
Profiling of Selected Medicinal Plants. Evidence-
Based Complementary and Alternative Medicine, 
2021. https://doi.org/10/gjxhzt 
20. Balouiri, M., Sadiki, M., & Ibnsouda, S. K. (2016). 
Methods for in vitro evaluating antimicrobial 
activity: A review. Journal of Pharmaceutical 
Analysis, 6(2), 71–79. 
https://doi.org/10.1016/j.jpha.2015.11.005 
21. Marasini, B. P., Baral, P., Aryal, P., Ghimire, K. R., 
Neupane, S., Dahal, N., Singh, A., Ghimire, L., & 
Shrestha, K. (2015, February 9). Evaluation of 
Antibacterial Activity of Some Traditionally Used 
Medicinal Plants against Human Pathogenic 
Bacteria [Research Article]. BioMed Research 
International; Hindawi. 
https://doi.org/10.1155/2015/265425 
22. Valgas, C., Souza, S. M. de, Smânia, E. F. A., & 
Smânia Jr., A. (2007). Screening methods to 
determine antibacterial activity of natural products. 
Brazilian Journal of Microbiology, 38(2), 369–380. 
https://doi.org/10/ftmw7n 
23. Kato, M., Sugiyama, K., Fukushima, T., Miura, Y., 
Awogi, T., Hikosaka, S., Kawakami, K., Nakajima, 
M., Nakamura, M., Sui, H., Watanabe, K., & Hakura, 
A. (2018). Negative and positive control ranges in 
the bacterial reverse mutation test: JEMS/BMS 
collaborative study. Genes and Environment, 40(1), 
7. https://doi.org/10.1186/s41021-018-0096-1 
24. CLSI. (2015). Performance standards for 
antimicrobial susceptibility testing: 25th 
informational supplement (M100-S23). Clinical and 
Laboratory Standards Institute. 
25. Mors, W. B., do Nascimento, M. C., Parente, J., da 
Silva, M. H., Melo, P. A., & Suarez-Kurtz, G. 
(1989). Neutralization of lethal and myotoxic 
activities of South American rattlesnake venom by 
extracts and constituents of the plant Eclipta prostrata 
(Asteraceae). Toxicon, 27(9), 1003–1009. 
https://doi.org/10.1016/0041-0101(89)90151-7 
26. Priya, K., John, P., Usha, P. T. A., Kariyil, B. J., 
Uma, R., & Hogale, M. S. (2018). Phytochemical 
Analysis of Eclipta prostrata L. (L.) Leaves. 
International Journal of Current Microbiology and 
Applied Sciences, 7(08), 1069–1075. 
https://doi.org/10.20546/ijcmas.2018.708.121 
27. Chung, I.-M., Rajakumar, G., Lee, J.-H., Kim, S.-H., 
& Thiruvengadam, M. (2017). Ethnopharmacological 
uses, phytochemistry, biological activities, and 
biotechnological applications of Eclipta prostrata. 
Applied Microbiology and Biotechnology, 101(13), 
5247–5257. https://doi.org/10.1007/s00253-017-
8363-9 
28. Kumar, D., Wani, T., Kumar, D., Prasad, R., Verma, 
P., Sardar, K., & Tandan, S. (2012). Analgesic 
activity of the ethanolic extract of Shorea robusta 
resin in experimental animals. Indian Journal of 
Pharmacology, 44(4), 493. 
https://doi.org/10.4103/0253-7613.99322 
29. Liu, J. (1995). Pharmacology of oleanolic acid and 
ursolic acid. Journal of Ethnopharmacology, 49(2), 
57–68. https://doi.org/10.1016/0378-8741(95)90032-
2 
30. Hong, S. S., Lee, S. A., Han, X. H., Lee, M. H., 
Hwang, J. S., Park, J. S., Oh, K.-W., Han, K., Lee, 
M. K., Lee, H., Kim, W., Lee, D., & Hwang, B. Y. 
(2008). Melampolides from the Leaves of 
Smallanthus sonchifolius and Their Inhibitory 
Activity of LPS-Induced Nitric Oxide Production. 
Chemical and Pharmaceutical Bulletin, 56(2), 199–
202. https://doi.org/10.1248/cpb.56.199 
31. Genta, S. B., Cabrera, W. M., Mercado, M. I., Grau, 
A., Catalán, C. A., & Sánchez, S. S. (2010). 
Hypoglycemic activity of leaf organic extracts from 
Smallanthus sonchifolius: Constituents of the most 
active fractions. Chemico-Biological Interactions, 
185(2), 143–152. 
https://doi.org/10.1016/j.cbi.2010.03.004 
32. Paudel, M. (1970). Non-timber forest products from 
community forestry practices, problems and 
prospects for livelihood strategy in Jumla. Banko 
Janakari, 17(2), 45–54. 
https://doi.org/10.3126/banko.v17i2.2155 
33. Taylor, R. S. L., Manandhar, N. P., Hudson, J. B., & 
Towers, G. H. N. (1996). Antiviral activities of 
Nepalese medicinal plants. Journal of 
Ethnopharmacology, 52(3), 157–163. 
https://doi.org/10.1016/0378-8741(96)01409-2 
34. Núñez-Sellés, A. J. (2005). Antioxidant therapy: 
Myth or reality? Journal of the Brazilian Chemical 
Society, 16(4), 699–710. 
https://doi.org/10.1590/S0103-50532005000500004 
35. Shah, K., Patel, M., Patel, R., & Parmar, P. (2010). 
Mangifera Indica (Mango). Pharmacognosy Reviews, 
4(7), 42. https://doi.org/10.4103/0973-7847.65325 
36. Jhaumeer Laulloo, S., Bhowon, M. G., Soyfoo, S., & 
Chua, L. S. (2018). Nutritional and Biological 
Evaluation of Leaves of Mangifera indica from 
Mauritius. Journal of Chemistry, 2018, 1–9. 
https://doi.org/10.1155/2018/6869294 
37. Katsube, T., Imawaka, N., Kawano, Y., Yamazaki, 
Y., Shiwaku, K., & Yamane, Y. (2006). Antioxidant 
flavonol glycosides in mulberry (Morus alba L.) 
leaves isolated based on LDL antioxidant activity. 
Food Chemistry, 97(1), 25–31. 
https://doi.org/10.1016/j.foodchem.2005.03.019 
38. Hikino, H., Takahashi, M., Oshima, Y., & Konno, C. 
(1988). Isolation and Hypoglycemic Activity of 
Oryzabrans A, B, C and D, Glycans of Oryza sativa 
Bran. Planta Medica, 54(01), 1–3. 
https://doi.org/10.1055/s-2006-962316 
39. Heinrich, M., Ankli, A., Frei, B., Weimann, C., & 
Sticher, O. (1998). Medicinal plants in Mexico: 
Healers’ consensus and cultural importance. Social 
Science & Medicine, 47(11), 1859–1871. 
https://doi.org/10.1016/S0277-9536(98)00181-6 
40. Díaz-de-Cerio, E., Verardo, V., Gómez-Caravaca, 
A., Fernández-Gutiérrez, A., & Segura-Carretero, A. 
(2016). Exploratory Characterization of Phenolic 
Nepal J Biotechnol. 2021  Jul ;9 (1): 5 0 -62      Shrestha et al. 
 
©NJB, BSN  61 
Compounds with Demonstrated Anti-Diabetic 
Activity in Guava Leaves at Different Oxidation 
States. International Journal of Molecular Sciences, 
17(5), 699. https://doi.org/10.3390/ijms17050699 
41. Shunying, Z., Yang, Y., Huaidong, Y., Yue, Y., & 
Guolin, Z. (2005). Chemical composition and 
antimicrobial activity of the essential oils of 
Chrysanthemum indicum. Journal of 
Ethnopharmacology, 96(1–2), 151–158. 
https://doi.org/10.1016/j.jep.2004.08.031 
42. Lee, D. Y., Choi, G., Yoon, T., Cheon, M. S., Choo, 
B. K., & Kim, H. K. (2009). Anti-inflammatory 
activity of Chrysanthemum indicum extract in acute 
and chronic cutaneous inflammation. Journal of 
Ethnopharmacology, 123(1), 149–154. 
https://doi.org/10.1016/j.jep.2009.02.009 
43. Indra, D. B., & Uppe, D. (2004). Factors controlling 
micropropagation of Myrica esculenta buch. Ham. ex 
D. Don: A high value wild edible of Kumaun 
Himalaya. African Journal of Biotechnology, 3(10), 
534–540. https://doi.org/10.5897/AJB2004.000-2097 
44. Gyawali, R., Adhikari, S., Gautam, S., Guragain, P., 
Pokharel, S., Pradhan, N., Sijapati, S., & Shrestha, T. 
M. (2015). Antimicrobial and cytotoxic properties of 
selected medicinal plants from Kavrepalanchowk, 
Nepal. Banko Janakari, 25(1), 15–19. 
https://doi.org/10.3126/banko.v25i1.13467 
45. Taylor, K. (2009). Biological Flora of the British 
Isles: Urtica dioica L. Journal of Ecology, 97(6), 
1436–1458. https://doi.org/10.1111/j.1365-
2745.2009.01575.x 
46. Ibrahim, M., Rehman, K., Razzaq, A., Hussain, I., 
Farooq, T., Hussain, A., & Akash, M. S. H. (2018). 
Investigations of Phytochemical Constituents and 
Their Pharmacological Properties Isolated from the 
Genus Urtica: Critical Review and Analysis. Critical 




47. Mankani, K. L., Krishna, V., Manjunatha, B. K., 
Vidya, S. M., Singh, S. J., Manohara, Y. N., 
Raheman, A.-U., & Avinash, K. R. (2005). 
Evaluation of hepatoprotective activity of stem bark 
of Pterocarpus marsupium Roxb. Indian Journal of 
Pharmacology, 37(3), 165. 
https://doi.org/10.4103/0253-7613.16213 
48. Jung, M., Park, M., Lee, H., Kang, Y.-H., Kang, E., 
& Kim, S. (2006). Antidiabetic Agents from 
Medicinal Plants. Current Medicinal Chemistry, 
13(10), 1203–1218. 
https://doi.org/10.2174/092986706776360860 
49. Negi, A., Upadhyay, A., Semwal, A., & Kumar 
Wahi, A. (2010). Pharmacognostical Studies on the 
Leaves of Eupatorium adenophorum Spreng. 
Pharmacognosy Journal, 2(15), 1–7. 
https://doi.org/10.1016/S0975-3575(10)80071-9 
50. Liu, B., Cao, L., Zhang, L., Yuan, X., & Zhao, B. 
(2016). Preparation, Phytochemical Investigation, 
and Safety Evaluation of Chlorogenic Acid Products 
from Eupatorium adenophorum. Molecules, 22(1), 
67. https://doi.org/10.3390/molecules22010067 
51. Grzanna, R., Lindmark, L., & Frondoza, C. G. 
(2005). Ginger—An Herbal Medicinal Product with 
Broad Anti-Inflammatory Actions. Journal of 
Medicinal Food, 8(2), 125–132. 
https://doi.org/10.1089/jmf.2005.8.125 
52. Singh, B. K., Tripathi, M., Chaudhari, B. P., Pandey, 
P. K., & Kakkar, P. (2012). Natural Terpenes Prevent 
Mitochondrial Dysfunction, Oxidative Stress and 
Release of Apoptotic Proteins during Nimesulide-
Hepatotoxicity in Rats. PLoS ONE, 7(4), e34200. 
https://doi.org/10.1371/journal.pone.0034200 
53. Negi, B. S., & Dave, B. P. (2010). In Vitro 
Antimicrobial Activity of Acacia catechu and Its 
Phytochemical Analysis. Indian Journal of 
Microbiology, 50(4), 369–374. 
https://doi.org/10.1007/s12088-011-0061-1 
54. Schoenfelder, T., Warmlin, C. Z., Manfredini, M. S., 
Pavei, L. L., Réus, J. V., Tristão, T. C., Fernandes, 
M. S., & Costa-Campos, L. (2010). Hypoglycemic 
and hypolipidemic effect of leaves from Syzygium 
cumini (L.) Skeels, Myrtaceae. In diabetic rats. 
Revista Brasileira de Farmacognosia, 20(2), 222–
227. https://doi.org/10.1590/S0102-
695X2010000200014 
55. Ruan, Z. P., Zhang, L. L., & Lin, Y. M. (2008). 
Evaluation of the Antioxidant Activity of Syzygium 
cumini Leaves. Molecules, 13(10), 2545–2556. 
https://doi.org/10.3390/molecules13102545 
56. Chagas, V. T., França, L. M., Malik, S., & Paes, A. 
M. de A. (2015). Syzygium cumini (L.) skeels: A 
prominent source of bioactive molecules against 
cardiometabolic diseases. Frontiers in 
Pharmacology, 6. 
https://doi.org/10.3389/fphar.2015.00259 
57. Hasan, M. M., Hossain, A., Shamim, A., & Rahman, 
M. M. (2017). Phytochemical and pharmacological 
evaluation of ethanolic extract of Lepisanthes 
rubiginosa L. leaves. BMC Complementary and 
Alternative Medicine, 17(1), 1–11. 
https://doi.org/10.1186/s12906-017-2010-y 
58. Kunwar, R. M., & Bussmann, R. W. (2008). 
Ethnobotany in the Nepal Himalaya. Journal of 
Ethnobiology and Ethnomedicine, 4, 1–8. 
https://doi.org/10.1186/1746-4269-4-24 
59. Turkmen, N., Sari, F., & Velioglu, Y. S. (2006). 
Effects of extraction solvents on concentration and 
antioxidant activity of black and black mate tea 
polyphenols determined by ferrous tartrate and Folin-
Ciocalteu methods. Food Chemistry, 99(4), 835–841. 
https://doi.org/10.1016/j.foodchem.2005.08.034 
60. Khorasani Esmaeili, A., Mat Taha, R., Mohajer, S., 
& Banisalam, B. (2015, May 6). Antioxidant Activity 
and Total Phenolic and Flavonoid Content of 
Various Solvent Extracts from In Vivo and In Vitro 
Grown Trifolium pratense L. (Red Clover) [Research 
Article]. BioMed Research International; Hindawi. 
https://doi.org/10.1155/2015/643285 
61. [61] Reznick, A. Z., Shehadeh, N., Shafir, Y., & 
Nagler, R. M. (2006). Free radicals related effects 
and antioxidants in saliva and serum of adolescents 
with Type 1 diabetes mellitus. Archives of Oral 
Nepal J Biotechnol. 2021  Jul ;9 (1): 5 0 -62      Shrestha et al. 
 
©NJB, BSN  62 
Biology, 51(8), 640–648. 
https://doi.org/10.1016/j.archoralbio.2006.02.004 
62. Khanna, V. G., & Kannabiran, K. (2008). 
Antimicrobial activity of saponin fractions of the 
leaves of Gymnema sylvestre and Eclipta prostrata. 
World Journal of Microbiology and Biotechnology, 
24(11), 2737. https://doi.org/10.1007/s11274-008-
9758-7 
63. Cherdtrakulkiat, R., Boonpangrak, S., Pingaew, R., 
Prachayasittikul, S., Ruchirawat, S., & 
Prachayasittikul, V. (2015). Bioactive triterpenoids, 
antimicrobial, antioxidant and cytotoxic activities of 
Eclipta prostrata Linn. -. Journal of Applied 
Pharmaceutical Science, 5(3), 046–050. 
64. Yu, S.-J., Yu, J.-H., He, F., Bao, J., Zhang, J.-S., 
Wang, Y.-Y., & Zhang, H. (2020). New antibacterial 
thiophenes from Eclipta prostrata. Fitoterapia, 142, 
104471. https://doi.org/10.1016/j.fitote.2020.104471 
65. Wei, H., Zhu, J.-J., Liu, X.-Q., Feng, W.-H., Wang, 
Z.-M., & Yan, L.-H. (2016). Review of bioactive 
compounds from root barks of Morus plants (Sang-
Bai-Pi) and their pharmacological effects. Cogent 
Chemistry, 2(1). 
https://doi.org/10.1080/23312009.2016.1212320 
66. Adeonipekun, P. A., Adeniyi, T. A., & Aminu, S. O. 
(2014). Investigating the Phytochemicals and 
Antimicrobial Activities of Shoot and Root of 
Pycreus smithianus (Ridl.) C. B. Clarke (Family 
Cyperaceae). Journal of Botany, 2014, 1–5. 
https://doi.org/10.1155/2014/761613 
67. Bouarab-Chibane, L., Forquet, V., Lantéri, P., 
Clément, Y., Léonard-Akkari, L., Oulahal, N., 
Degraeve, P., & Bordes, C. (2019). Antibacterial 
Properties of Polyphenols: Characterization and 
QSAR (Quantitative Structure–Activity 
Relationship) Models. Frontiers in Microbiology, 10. 
https://doi.org/10.3389/fmicb.2019.00829 
68. Takó, M., Kerekes, E. B., Zambrano, C., Kotogán, 
A., Papp, T., Krisch, J., & Vágvölgyi, C. (2020). 
Plant Phenolics and Phenolic-Enriched Extracts as 
Antimicrobial Agents against Food-Contaminating 
Microorganisms. Antioxidants, 9(2), 165. 
https://doi.org/10.3390/antiox9020165 
69. Vu, T. T., Kim, H., Tran, V. K., Vu, H. D., Hoang, T. 
X., Han, J. W., Choi, Y. H., Jang, K. S., Choi, G. J., 
& Kim, J.-C. (2017). Antibacterial activity of tannins 
isolated from Sapium baccatum extract and use for 
control of tomato bacterial wilt. PLOS ONE, 12(7), 
e0181499. 
https://doi.org/10.1371/journal.pone.0181499 
 
 
